Effects of shrimp (M0acrobracium rosenbergii)-derived chitosan on plasma lipid profile and liver lipid peroxide levels in normo- and hypercholesterolaemic rats

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 3, 2007, Pages 170-176

  Hossain, Shahdat ^a   Rahman, Azizur ^a   Kabir, Yearul ^b   Shams, Ali Ahmed ^a   Afros, Fahmida ^a   Hashimoto, Michio ^c  

^a JAHANGIRNAGAR UNIVERSITY   (Bangladesh)

^b KUWAIT UNIVERSITY   (Kuwait)

^c SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Chitosan; Exoskeleton; Hypercholesterolaemia; Lipids; Shrimp

Indexed keywords

ALANINE AMINOTRANSFERASE; ARACHIDONIC ACID; CHITOSAN; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ASPARTATE AMINOTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; ENZYME ASSAY; FATTY ACID ANALYSIS; FEMALE; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID LIVER LEVEL; NONHUMAN; RAT; SHRIMP; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ANIMAL; BLOOD; CHEMISTRY; DEALKYLATION; DIET; EATING; ISOLATION AND PURIFICATION; LIVER; LONG EVANS RAT; METABOLISM; PENAEIDAE;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; CHITOSAN; DEALKYLATION; DIET; EATING; FATTY ACIDS; FEMALE; HYPERCHOLESTEROLEMIA; LIPID PEROXIDES; LIPIDS; LIVER; PENAEIDAE; RATS; RATS, LONG-EVANS;

EID: 33846434044     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04568.x     Document Type: Article

References (34)

1. Biagini G, Bertani A, Muzzarelli R et al. Wound management with N-carboxybutyl chitosan. Biomaterials 1991; 12: 281-6.
2. Sakkinen M, Seppala U, Heinanen P, Marvola M. In vitro evaluation of microcrystalline chitosan (MCCh) as gel-forming excipient in matrix granules. Eur. J. Pharm. Biopharm. 2002; 54: 33-4.
3. Nunthanid J, Laungtana-Anan M, Sriamornsak P et al. Characterization of chitosan acetate as a binder for sustained release tablets. J. Control. Release 2004; 99: 15-26.
4. Ventura P. Lipid lowering activity of chitosan, a new dietary integrator. In: Muzzarelli RAA (ed). Chitin Enzymology, Vol. 2. Atec Edizioni, Ancona. 1996; 55-62.
5. Sugano M, Fujikawa T, Hiratsuji Y, Nakashima K, Fukuda N, Hasegawa Y. A novel use of chitosan as a hypocholesterolemic agent in rats. Am. J. Clin. Nutr. 1980; 33: 787-93.
6. LeHoux J-G, Grondin F. Some effects of chitosan on liver function in the rat. Endocrinology 1993; 132: 1078-84.
7. Hegsted DM, Ausman L, Johnson JA, Dallal GE. Dietary fat and serum lipids: An evaluation of the experimental data. Am. J. Clin. Nutr. 1993; 57: 875-83.
8. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: Prevalence and trends, 1960-94. Int. J. Obes. Relat. Metab. Disord. 1998; 22: 39-47.
9. Troiano RP, Flegal KM. Overweight children and adolescents: Description, epidemiology, and demographics. Pediatrics 1998; 101: 497-504.
10. Ormrod DJ, Holmes CC, Miller TE. Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis 1998; 13: 329-34.
11. Muzzarelli RAA, Ilari P, Petrarulo M. Solubility and structure of N-carboxy methylchitosan. Int. J. Biol. Macromol. 1994; 16: 177-80.
12. Sabnis S, Block LH. Improved infrared spectroscopic method for the analysis of degree of N-deacetylation of chitosan. Polym. Bull. 1997; 39: 67-71.
13. Folch J, Lees M, Sloane-Stanely GH. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957; 226: 497-509.
14. Ohkawa H, Ohnishi N, Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal. Biochem. 1979; 95: 351-8.
15. Hashimoto M, Shinozuka K, Shahdat H et al. Antihypertensive effects of all-cis-5,8,11,14,17-icosapentaenoate of aged rats is associated with an increase in the release of ATP from caudal artery. J. Vasc. Res. 1998: 35: 55-62.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin reagent. J. Biol. Chem. 1951; 193: 265-75.
17. Simopoulus AP, Pavlou KN (eds). Nutrition and Fitness, Metaboilic and Behavioral Aspects in Health and Disease. World Review of Nutrition and Dietetics, Vol. 82. Karger, Basel. 1997.
18. Ho SC, Tai ES, Eng PH, Tan CE, Fok AC. In the absence of dietary surveillance, chitosan does not reduce plasma lipids or obesity in hypercholesterolaemic obese Asian subjects. Singapore Med. J. 2001; 42: 6-10.
19. Mhurchi CN, Dunshea-Mooji C, Bennett D, Rodgers A. Effect of chitosan on weight loss in overweight and obese individuals: A systematic review of randomized controlled trials. Obes. Rev. 2005; 6: 3-4.
20. Deuchi K, Kanauchi O, Imasato Y, Kobayashi E. Decreasing effect of chitosan on the apparent fat digestibility by rats fed on a high fat diet. Biosci. Biotech. Biochem. 1994; 58: 1613-16.
21. Bokura H, Kobayashi S. Chitosan decreases total cholesterol in women: A randomized, double-blind, placebo-controlled trial. Eur. J. Clin. Nutr. 2003; 57: 721-5.
22. Tai TS, Sheu WH-H, Lee WJ, Yao HT, Chiang MT. Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia. Diabetes Care 2000; 23: 1703-4.
23. Kanauchi O, Deuchi K, Imasato Y, Shizukuishi M, Kobayashi E. Mechanism for the inhibition of fat digestion by chitosan and for the synergistic effect of ascorbate. Biosci. Biotechnol. Biochem. 1995; 59: 786-90.
24. Bilheimer DM. The lipoprotein receptor concept. Drugs 1988; 36: 55-62.
25. Deuchi K, Kanauchi O, Imasato Y, Kobayashi E. Effect of the viscosity or deacetylation degree of chitosan on fecal fat excreted from rats fed on a high-fat diet. Biosci. Biotechnol. Biochem. 1995; 59: 781-5.
26. Lengsfeld H, Fleury A, Nolte M, Piquerez JC, Hadvary P, Beglinger C. Effect of orlistat and chitosan on faecal fat excretion in young healthy volunteers. Obes. Res. 1999; 7 (Suppl. 1): S50 (Abstract).
27. Sharma CP, Chandy T, Kumari TV, Paul W. Lipoprotein adsorption onto modified chitosan beads. Biomater. Artif. Cells Immobil. Biotechnol. 1993; 21: 659-64.
28. Yihua YU, Binglin HE. A new low-density lipoprotein (LDL) adsorbent. Artif. Cells Blood Substit. Immobil. Biotechnol. 1997; 25: 445-50.
29. Wuolijoki E, Hirvela T, Ylitalo P. Decrease in serum LDL cholesterol with microcrystalline chitosan. Methods Find. Exp. Clin. Pharmacol. 1999; 21: 357-61.
30. Gylling H, Miettinen TA. Cholesterol absorption: Influence of body weight and the role of plant sterols. Curr. Atheroscler. Rep. 2005; 7: 466-71.
31. Piche LA, Draper HH, Cole PD. Malondialdehyde excretion by subjects consuming cod liver oil vs. C concentrate n-3 fatty acids. Lipids 1988; 45: 337-51.
32. Halliwell B, Gutteridg JMC. Free Radicals in Biology and Medicine. Claredon Press, Oxford. 1989.
33. Deuchi K, Kanauchi O, Shizukuishi M, Kobayashi E. Continuous and massive intake of chitosan affects mineral and fat-soluble vitamin status in rats fed on a high-fat diet. Biosci. Biotechnol. Biochem. 1995; 59: 1211-16.
34. Sayeed MA, Mahtab H, Khanam PA et al. Diabetes and impaired fasting glycemia in a rural population of Bangladesh. Diabetes Care 2003; 26: 1034-9.